Serum profile of bile acids in critical conditions

• Conditions: I60; S06; I62; T07; I63; I21; I38; I51; J44; J18

• Registration Number: DRKS00027584
• Lead Sponsor: niversitätsmedizin GöttingenKlinik für Anästhesiologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-07
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

Female, male, and diverse patients
- Age > 18 years
- Intracranial hemorrhage (subarachnoid hemorrhage traumatic and spontaneous, subdural hematoma acute and chronic, epidural hematoma, intraparenchymal intracranial hemorrhage)
- Trauma (polytrauma, multiple injuries, single injuries)
- Stroke (ischemic)
- acute myocardial infarction
- valvular endocarditis
- acute cardiac decompensation
- respiratory insufficiency (exacerbated COPD, acute pneumonia of any cause, ARDS)
- sepsis of any cause
- all forms of shock (hypovolemic, distributive, obstructive, cardiogenic)
- Treatment in intensive care units 0119/0116/0041/0141

Exclusion Criteria

- Age < 18 years
- Lack of consent
- Refusal to participate in the study

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bile acids in serum at different time points in the course of the disease (observational/descriptive).